Stockwinners Market Radar for June 15, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:32 EDT Canadian National receives strike notice from IBEW union - The company states: "CN confirmed that the International Brotherhood of Electrical Workers, or IBEW, which represents approximately 750 employees in Canada, has given the Company a 72-hour notice of its intention to strike as of 11:00 AM Eastern Time on June 18, 2022. CN has negotiated with the union in good faith and will continue to do so. The Company has also offered to resolve the remaining differences, which are predominantly on wages and benefits, through binding arbitration. CN remains optimistic that an agreement can be reached without a labour disruption. However, should the union move forward with a strike, CN has prepared and is ready to implement an operational contingency plan. This plan would ensure a normal level of continued safe operations as long as required."

20:05 EDT Cathie Wood's ARK Investment bought 85.6K shares of Zymergen today

19:11 EDT Huntington Bancshares raises prime rate to 4.75% - Huntington Bancshares announced that its prime rate is increasing from 4% to 4.75%, effective June 16, 2022.

18:45 EDT Dutch Bros CEO: Demand is not where we would like it to be - In an interview on CNBC's Mad Money, Joth Ricci said there are tough headwinds for the consumer. Business has softened in the afternoon, he noted. The company has not raised prices in an aggressive way and will evaluate price actions again in the fall. "We want to take care of the customer. We're very mindful of that," he added.

18:17 EDT Banco Santander raises prime rate to 4.75% - Santander Bank has raised its prime rate from 4.00% to 4.75%, effective June 15.

18:01 EDT Valens receives Nasdaq notification regarding minimum bid price deficiency - The Valens Company announced that on June 13, 2022, it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the company is not in compliance with the minimum bid price requirement of $1.00 per share under the Nasdaq Listing Rules. Based on the closing bid price of the company's common shares for the last 30 consecutive business days, the company has failed to meet the Minimum Bid Requirement set forth in Listing Rule 5550(a)(2) during that period. The Notice is only a notification of deficiency, it is not a notice of imminent delisting, and it has no current immediate effect on the listing or trading of the company's common shares on the Nasdaq Capital Market.

17:48 EDT Deutsche Bank raises prime lending rate to 4.75% - Deutsche Bank "announced that its New York Branch, Deutsche Bank New York and its affiliate Deutsche Bank Trust Company Americas have increased their prime lending from 4.00% to 4.75% effective tomorrow, June 16, 2022."

17:41 EDT Adtalem Global Education director Krehbiel purchases $316.7K in shares - Director of Adtalem Global Education William Krehbiel purchased 10,000 shares of company stock at $31.67 per share. on June 14, for a total transaction amount of $316,700.

17:30 EDT U.S. Bancorp raises prime lending rate to 4.75% - U.S. Bancorp announced it has increased its prime lending rate to 4.75% from 4.00%, effective tomorrow, June 16, 2022, at all U.S. Bank locations.

17:27 EDT City Office REIT announces sale of Lake Vista Pointe property for $43.8M - City Office REIT "announced that it has completed the previously announced sale of its Lake Vista Pointe property in Dallas, Texas for a gross sale price of $43.8 million inclusive of certain transaction costs that the buyer is responsible for paying."

17:24 EDT PNC Financial increases prime lending rate to 4.75% - PNC Bank, N.A. announced an increase in its prime lending rate. The new rate of 4.75% is effective tomorrow, June 16, 2022.

17:02 EDT Frontdoor names Jessica Fields as Chief Sales Officer - Frontdoor has appointed Jessica Fields as VP and Chief Sales Officer. Fields joins Frontdoor from Rocket Mortgage, where she served as EVP and Channel Revenue Officer and managed partnerships across the real estate, insurance and finance sectors. In addition, she served as EVP, Strategy and Business Development, with Rocket Homes, a home search and selling platform and agent referral network.

17:00 EDT Webster Financial raises prime lending rate to 4.75% from 4% - Webster Financial announced that it has raised its prime lending rate to 4.75% from 4%, effective June 16.

16:36 EDT Montauk Renewables to join Russell 3000 Index - Montauk Renewables announced that it will join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the U.S. market opens on June 27, according to a preliminary list of additions posted June 3. In addition, Montauk Renewables was recently added to the MSCI Global Small Cap Indexes within the MSCI USA Small Cap Index, which became effective after the market close on May, 31.

16:31 EDT Kraton announces price increase for HSBC polymers - Kraton "announces a general price increase of $330/MT for all Kraton HSBC polymers. Given the unprecedented increases in raw materials, energy, and logistics, this price increase will be applied to all HSBC polymers."

16:31 EDT Wells Fargo raises prime rate to 4.75% from 4% - Wells Fargo said it is increasing its prime rate to 4.75% from 4%, effective tomorrow, June 16, 2022.

16:20 EDT W. R. Berkley raises quarterly dividend 15.3% to 10c per share - W. R. Berkley Corporation announced that its Board of Directors has voted to increase the regular cash dividend to an annual rate of 40c per share, representing a 15.3% increase from the present rate. The first regular quarterly cash dividend at the new rate of 10c per share will be paid on July 7, 2022 to stockholders of record at the close of business on June 27, 2022. The per share dividend amounts above reflect the 3-for-2 common stock split effected on March 23, 2022. In addition, the Board of Directors has declared a special cash dividend on its common stock of 50c per share to be paid on July 7, 2022 to stockholders of record at the close of business on June 27, 2022.

16:18 EDT Ladder Capital raises quarterly dividend by 10% to 22c per share - The cash dividend is payable on July 15, 2022 to stockholders of record as of the close of business on June 30, 2022.

16:16 EDT Associated Banc-Corp raises prime rate to 4.75% from 4.00%, effective June 15

16:15 EDT TriNet appoints Chief Digital and Innovation Officer, Chief Technology Officer - TriNet announced that effective June 30, Chief Digital and Innovation Officer Jay Venkat and Chief Technology Officer Jeff Hayward will be added to the executive team. Both positions report directly to TriNet President and CEO Burton M. Goldfield. Venkat comes to TriNet from Boston Consulting Group, where he spent the majority of his two-decade career, and where he currently leads the Technology, Media and Telecom practice area in North America, as well as the Firm's San Francisco and Silicon Valley Offices. Hayward most recently served as Senior VP of Product Engineering for Airline Solutions at Sabre. He has also held leadership roles both domestically and internationally for leading technology companies Unisys, Dell EMC and others.

16:08 EDT Allison Transmission reports arrival hybrid buses with eGen Flex at IndyGo - Allison Transmission (ALSN) announced that in partnership with GILLIG and Cummins (CMI), the first buses equipped with its Allison eGen FlexT electric hybrid propulsion system have arrived at the Indianapolis Public Transportation Corporation. The eGen Flex is the next generation of Allison's proven H 40 EP electric hybrid propulsion system, which has been operating in select IndyGo buses since 2004. In addition to the benefits provided by the H 40 EP, such as improving fuel consumption by up to 25% versus a conventional diesel bus, the eGen Flex provides revolutionary capabilities which include full electrification range. "IndyGo's continued collaboration with Allison represents our joint mission and commitment to reduce our carbon footprint in the Indianapolis community," said Inez Evans, IndyGo President and CEO. "The delivery of the GILLIG buses equipped with the eGen Flex technology represents the next step in our efforts to reduce our dependence on fossil fuels, enhance quality of life for residents and do our part to protect the environment."

16:06 EDT Vectrus shareholders approve combination with Vertex - Vectrus shareholders voted to approve the combination with Vertex. Following the close of the transaction, the combined company will be renamed V2X, and its common stock will trade on the NYSE under a new ticker symbol, "VVX". Under the terms of the merger agreement, Vertex shareholders will own approximately 62% of the combined company on a fully diluted basis, while Vectrus shareholders will own approximately 38%. The merger is expected to close early in Q3, and remains subject to satisfaction of customary closing conditions, including receipt of regulatory approvals.

16:06 EDT Rockley Photonics CFO Mahesh Karanth to step down - The company states: "Rockley Photonics "announced changes to its senior management team. These changes are intended to align with the Company's next phase of growth as it prepares to begin production of its biosensing solution following completion of its recent $81.5 million private placement. As part of these changes, the Company announced that Mahesh Karanth will resign from his role as CFO to pursue other interests. Chad Becker, vice president of financial planning and analysis, will be promoted to the role of interim CFO effective immediately. Mr. Becker brings 20 years of finance and leadership experience at companies, including Microsoft and NetApp."

16:06 EDT Quoin gets Nasdaq letter on non-compliance with minimum bid price - Quoin Pharmaceuticals announced that the Company received a written notification from the Nasdaq Stock Market on June 10 with the minimum bid price that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on Nasdaq. Nasdaq Rule 5550a2 which requires listed securities to maintain a minimum bid price of US$1.00 per share. The Notification Letter does not impact the Company's listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Rule 5810c3A, the Company has been provided 180 calendar days, or until December 7 to regain compliance with Nasdaq Rule 555a2. To regain compliance, the Company's American Depositary Shares representing ordinary shares must have a closing bid price of at least US$1.00 per ADS for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by December 7 the Company may be eligible for additional time to regain compliance or may face delisting. The Company's business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its ADSs and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Rules.

16:05 EDT Safehold increases quarterly stock dividend 4.12% to 17.7c per share - Safehold has declared common stock dividends of 17.7c per share for 2Q22. The dividend represents an annualized rate of 70.8c per share and is payable on July 15 to holders of record on June 30.

15:54 EDT FDA panel backs Pfizer COVID-19 vaccine for children aged 6 months to 4 years - FDA advisers voted unanimously that the benefits of Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine three-dose series outweigh the risks for children aged 6 months through 4 years, with 21 votes for "yes" and zero "no" votes, according to multiple reports of the ongoing advisory committee meeting.

15:25 EDT KeyCorp raises prime lending rate to 4.75% from 4% - KeyCorp and its banking affiliates have raised their prime lending rate to 4.75% from 4%, effective June 16.

14:48 EDT Exxon Mobil 'in regular contact' with Biden administration on U.S. investments - ExxonMobil released the following statement in response to a letter from President Biden: "We have been in regular contact with the administration to update the President and his staff on how ExxonMobil has been investing more than any other company to develop U.S. oil and gas supplies. This includes investments in the U.S. of more than $50 billion over the past five years, resulting in an almost 50% increase in our U.S. production of oil during this period. Globally, we've invested double what we've earned over the past five years -- $118 billion on new oil and gas supplies compared to net income of $55 billion. This is a reflection of the company's long-term growth strategy, and our commitment to continuously invest to meet society's demand for our products. Specific to refining capacity in the U.S., we've been investing through the downturn to increase refining capacity to process U.S. light crude by about 250,000 barrels per day - the equivalent of adding a new medium-sized refinery. We kept investing even during the pandemic, when we lost more than $20 billion and had to borrow more than $30 billion to maintain investment to increase capacity to be ready for post-pandemic demand. In the short term, the U.S. government could enact measures often used in emergencies following hurricanes or other supply disruptions -- such as waivers of Jones Act provisions and some fuel specifications to increase supplies. Longer term, government can promote investment through clear and consistent policy that supports U.S. resource development, such as regular and predictable lease sales, as well as streamlined regulatory approval and support for infrastructure such as pipelines."

13:34 EDT North American rail traffic fell 3.3% for the week ending June 11 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending June 11. For this week, total U.S. weekly rail traffic was 510,295 carloads and intermodal units, down 3.6% compared with the same week last year. Total carloads for the week ending June 11 were 234,942 carloads, down 2.8% compared with the same week in 2021, while U.S. weekly intermodal volume was 275,353 containers and trailers, down 4.4% compared to 2021. Three of the 10 carload commodity groups posted an increase compared with the same week in 2021. They were motor vehicles and parts, up 1,571 carloads, to 13,793; farm products excl. grain, and food, up 1,203 carloads, to 16,340; and nonmetallic minerals, up 618 carloads, to 33,028. Commodity groups that posted decreases compared with the same week in 2021 included grain, down 2,912 carloads, to 21,429; coal, down 2,657 carloads, to 66,607; and miscellaneous carloads, down 1,466 carloads, to 9,769. North American rail volume for the week ending June 11, 2022, on 12 reporting U.S., Canadian and Mexican railroads totaled 332,226 carloads, down 2.5% compared with the same week last year, and 363,156 intermodal units, down 4.1% compared with last year. Total combined weekly rail traffic in North America was 695,382 carloads and intermodal units, down 3.3%. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Trinity Industries (TRN), Greenbrier (GBX), FreightCar America (RAIL) and Wabtec (WAB). Reference Link

13:02 EDT United Airlines debuts plant-based menu items from Impossible Foods - United Airlines (UAL) is adding two new Impossible Foods menu items on select flights and in certain airport lounges, as part of the carrier's new push to add more plant-based options to its food offerings. As part of a new collaboration between United and Impossible Foods, the United-exclusive Impossible Meatball Bowl is now available to first class customers on all domestic flights more than 800 miles in the continental U.S. The Impossible Sausage is available in Polaris lounges in Chicago, Los Angeles, Newark and San Francisco. The Fly notes that Beyond Meat (BYND) is a publicly-traded competitor of Impossible Foods.

12:10 EDT General Motors CFO: Orders for electric vehicles remain strong

12:09 EDT General Motors on track for FY adjusted EBIT target of $13B-$15B, says CFO

12:00 EDT Community Health falls -10.1% - Community Health is down -10.1%, or -48c to $4.30.

12:00 EDT Cooper-Standard falls -18.2% - Cooper-Standard is down -18.2%, or -92c to $4.13.

12:00 EDT Tupperware Brands rises 13.3% - Tupperware Brands is up 13.3%, or 77c to $6.58.

11:59 EDT Great Southern Bancorp raises quarter dividend 11% to 40c per share - The Board of Directors of Great Southern Bancorp declared a 40c per common share dividend for the second quarter of the calendar year ending December 31, 2022. This dividend represents an 11% increase from the previous quarter's dividend of 36c per common share.

11:51 EDT C3 Industries partners Red White & Bloom to license Platinum Vape brand - C3 Industries announced an exclusive partnership with Red White & Bloom to license their Platinum Vape brand in Missouri and Massachusetts. C3 Industries will exclusively license the full line of Platinum Vape products in Missouri and Massachusetts, with items available for sale in High Profile Cannabis shops and third-party retailers across the states. The initial offering will include the following flavors of cartridges: Grease Monkey; Sour Dub; Lime OG; Fire OG; Grape Ape; Paris OG; Maui Wowie; Super Lemon Haze; and Cush.

11:33 EDT Cisco announces launches of Panoptica and Calisti API-first solutions - Cisco announced it has launched Panoptica and Calisti, which the company calls "the latest additions to Cisco's suite of cloud-native, API-first solutions and tools that result in faster application development cycles, and provide businesses with modern application connectivity, security, and observability that is critical for exceptional digital experiences." Cisco added: "These software products underscore the company's strategy towards managing and securing distributed application architectures, making it possible for developers to programmatically discover, connect, secure and observe APIs, applications and workloads across the breadth of their cloud journey from born-in-the-cloud use cases on a singular cloud, to hybrid and multi-cloud architectures that span public, private, SaaS, and edge components." Reference Link

11:16 EDT Knightscope announces contract renewal from real estate investment firm - Knightscope announced that a San Francisco based real estate investment firm renewed its Machine-as-a-Service subscription agreement for a fourth year. The K5 Autonomous Security Robot has been watching over a multi-story parking structure since 2019 and will continue to help detect unauthorized parking, ward off criminal mischief and provide coverage in areas where fixed cameras fail to reach. Client renewals are essential to Knightscope's growth strategy and prove to validate the longevity and effectiveness of the technology to new, incoming clients.

11:02 EDT Bank of America reports May charge-offs 1.42% vs. 1.46% last month - Reports May 30-plus day delinquencies 0.84% vs. 0.88% last month.

10:42 EDT Innovation Pharmaceuticals acquires stake in Sqaulus Medical - Innovation Pharmaceuticals announced that the Company has acquired a minority stake in Israel-based Squalus Medical, the inventor and developer of the StingRay Laser System, a novel laser-based thermal ablation technology designed for treatment of previously inoperable cases of epilepsy and for improvement of outcomes and enablement of new treatment options for oncology procedures, including those treating brain, prostate, liver, breast and lung cancers. The StingRay System combines new fiber optic technology with an advanced laser console and computerized intelligent control that allows an excellent match between the structure of tumors and epileptic focal points and the energy delivery, while protecting vital functional areas against thermal damage. The console integrates advanced imaging modalities, and guides the physician, making sure the treatment is adjusted to the specific patient needs with real time energy control. The StingRay System is supported by Squalus' proprietary technologies that deliver remarkable properties for controlling laser energy. These include: DiLITT -- Directional Laser Interstitial Thermal Therapy. DiLITT provides the ability to treat distorted or irregular shapes through accurate control of the angular energy distribution. ExLITT -- Extended LITT. ExLITT offers the ability to easily treat large volumes through radial control of the energy. APM -- Advanced Planning Module. These are the software tools that control the laser and do the matching between the lesion shape and energy using smart AI based algorithms.

10:37 EDT AlphaSense's valuation jumps to $1.7B with $225M Series D led by GSAM - AlphaSense, a market intelligence and search platform, announced its $225M Series D financing round led by the Growth Equity business within Goldman Sachs Asset Management and Viking Global Investors. The financing values the company at $1.7B, which is nearly double the valuation from its $180 million Series C funding in September 2021 that was also led by Goldman Sachs and Viking Global, the company said in a statement. This new funding round includes a substantial debt investment from funds and/or accounts managed by BlackRock earlier this year.

10:35 EDT TrueBlue names Chairman Steven Cooper as CEO

10:34 EDT TrueBlue investigation found Beharelle's behaviors violated code of conduct

10:33 EDT Ford Credit seeing delinquencies start to increase, says CFO Lawler - Lawler says increased delinquencies are "not yet a concern for us," and that "we're reverting back more towards the mean."

10:32 EDT Ford CFO John Lawler says demand continues to be 'very robust' - Comments taken from the Deutsche Bank Global Auto Industry Conference.

10:23 EDT MicroStrategy up 8% to $170, off highs as CEO interview ends on CNBC

10:19 EDT MicroStrategy CEO says excess cash will be used to buy more bitcoin - MicroStrategy CEO Michael Saylor is speaking on CNBC.

10:13 EDT MicroStrategy CEO says balance sheet 'fortress,' margin 'well managed' - MicroStrategy CEO Michael Saylor is speaking on CNBC.

10:12 EDT MicroStrategy CEO says current bitcoin levels 'ideal entry point' - MicroStrategy CEO Michael Saylor is speaking on CNBC.

10:11 EDT MicroStrategy CEO says bitcoin 'risk-off' asset when looking long term - MicroStrategy CEO Michael Saylor is speaking on CNBC.

10:08 EDT Converge Technology to acquire Gesellschaft fur digitale Bildung - Converge Technology Solutions is pleased to announce it has entered into a definitive agreement to acquire Germany-based organizations Gesellschaft fur digitale Bildung ("GfdB"), Institut fur moderne Bildung, and DEQSTER. Headquartered in Germany, GfdB, IfmB, and DEQSTER are all education market focused organizations enabling schools and universities to implement their digital future. GfdB and IfmB are full-service IT suppliers for education, offering everything from hardware and software to advanced training and comprehensive technical/consulting services. DEQSTER specializes in the development and production of equipment for digital learning and working, with a broad portfolio comprising of tablet cases, protective sleeves, digital pencils, and more. With these acquisitions and in combination with previously acquired REDNET, A Converge Company, and Visucom, A Converge Company, Converge will be a leading education partner in the German market. The new alliance between GfdB, IfmB, DEQSTER, REDNET, and Visucom allows all organizations to enhance and strengthen their solutions, services, and offering, as well as develop new strategies to better serve the education sector in Germany. This enhanced portfolio will include a tailored 360 degrees approach that furthers education to professional and managed services, logistics & system configuration, technical services, and parental financing.

10:04 EDT AgroFresh, Novozymes to explore development of biological solutions - Novozymes (NVZMY) and AgroFresh (AGFS) are forming a research and commercialization partnership towards developing biological solutions that can improve post-harvest food quality and minimize waste by fighting fungal pathogens. Resulting products, which will be developed for post-harvest applications, will benefit growers, retailers, and consumers, as well as the environment. Around one third of food produced is lost or wasted before it even gets to the consumer, with fruits and vegetables accounting for over half of this amount. As soon as crops are harvested and removed from their growing environment, they begin to lose quality and eventually deteriorate. Fresh crops, such as fruits, vegetables, and flowers, are particularly vulnerable to microbial attack and subsequent losses during this post-harvest stage, which includes cooling, cleaning, sorting, and packing of the crop. Novozymes and AgroFresh anticipate that development of new bioproducts will be accelerated by the combination of advanced biotechnologies from Novozymes and AgroFresh's deep scientific expertise in post-harvest solutions, global commercial footprint, and unparalleled portfolio of integrated solutions to help maintain freshness and quality of fruits, vegetables, and flowers. Novozymes and AgroFresh have entered into a strategic collaboration agreement that will explore co-development of biological based solutions to control fungal pathogens in fruits, vegetables, and flowers, and will leverage the AgroFresh commercial footprint. AgroFresh will lead the commercialization of these new solutions for post-harvest application in fruits, vegetables, and flowers. Novozymes' BioAg business produces biological solutions for both broad acre and specialty crops. Its products increase plant productivity and protect crops from pests so farmers can produce more food, feed, and fuel with fewer inputs and on less land.

10:00 EDT Citi up 2.6% to $47.17 amid Morgan Stanley conference presentation

10:00 EDT Cooper-Standard falls -11.5% - Cooper-Standard is down -11.5%, or -58c to $4.47.

10:00 EDT Carvana rises 8.9% - Carvana is up 8.9%, or $1.86 to $22.78.

10:00 EDT Tupperware Brands rises 10.2% - Tupperware Brands is up 10.2%, or 59c to $6.40.

09:58 EDT Citi's Morton: Move in the dollar has been 'unprecedented'

09:57 EDT Citi sees Q2 trading revenue up 'north of 25%' y/y - Comments taken from the Morgan Stanley U.S. Financials, Payments & CRE Conference.

09:47 EDT Oscar Health falls -6.9% - Oscar Health is down -6.9%, or -29c to $3.90.

09:47 EDT Cooper-Standard falls -10.8% - Cooper-Standard is down -10.8%, or -55c to $4.50.

09:47 EDT New Oriental Education rises 10.0% - New Oriental Education is up 10.0%, or $2.13 to $23.40.

09:42 EDT Zhong Yang Financial Group Ltd trading resumes

09:39 EDT Eltek reports contained fire at plant in Petah Tikva - Eltek informed that yesterday evening, a fire broke out in one of the production rooms in the Company's plant in Petach-Tikva. The fire, which damaged part of the production line located in that room, was extinguished without any casualties. The company restarted its manufacturing in all other production lines; however the manufacturing processes performed in the room that was damaged are required for completing the manufacturing process. At this stage a full assessment of the full recovery time and the impact on the company's operations has not been completed. The Company is making efforts to minimize delays of its products deliveries. Based on a preliminary review, all damages are covered under the Company's insurance policies.

09:37 EDT Meihua International Medical Tech Co Ltd trading resumes

09:32 EDT Meihua International Medical Tech Co Ltd trading halted, volatility trading pause

09:32 EDT Zhong Yang Financial Group Ltd trading halted, volatility trading pause

09:28 EDT Allarity appoints Roberto Pili to scientific advisory board - Allarity Therapeutics announced the appointment of Roberto Pili, M.D., as a member of the Company's Scientific Advisory Board. Dr. Pili is Associate Dean for cancer research and integrative oncology and Professor and Chief of the Division of Hematology/Oncology in the Department of Medicine at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo.

09:22 EDT Diana Shipping announces sale of m/v Baltimore to OceanPal for $22M - Diana Shipping (DSX) announced that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to sell one of its dry bulk vessels, the m/v Baltimore, to OceanPal (OP), a related party. The aggregate sale price of the vessel is $22M, 20% of which was paid upon signing of the Memorandum of Agreement and 80% of which will be paid upon the delivery of the vessel in the form of newly issued preferred shares of OceanPal Inc. The terms of the preferred shares will be mutually agreeable between the Company and OceanPal Inc., and are expected to include a preferred dividend and to be convertible into OceanPal Inc. common shares at any time. The aggregate sale price was agreed upon based on the average of two independent broker vessel valuations, adjusted for a scheduled drydocking of the vessel prior to delivery to OceanPal Inc. and taking into account the share-based component of the consideration. The m/v Baltimore is a 2005-built Capesize dry bulk vessel having a carrying capacity of 177,243 dwt. Delivery to the buyer is expected to occur in the third quarter of 2022 following the completion of the vessel's scheduled drydocking. The sale and purchase of the vessel was made pursuant to OceanPal Inc.'s exercise of a right of first refusal granted by the Company on six identified vessels based on an agreement dated November 8, 2021. The sale of the m/v Baltimore to OceanPal Inc. was approved by a committee of independent members of the Company's Board of Directors.

09:19 EDT Amazon, Cartier file two joint counterfeit luxury goods lawsuits - Amazon and Cartier announced two joint lawsuits against a social media influencer and eight businesses for advertising, promoting, and facilitating the sale of counterfeit luxury goods through Instagram and other websites, infringing on Cartier's registered trademarks and violating Amazon's policies. The lawsuits were filed in the United States District Court for the Western District of Washington and allege the defendants colluded with each other to sell counterfeit products and engage in false advertising. Among the nine defendants, the lawsuits allege that a social media influencer conspired with bad actors to attempt to circumvent Amazon's anti-counterfeiting detection tools by promoting counterfeit luxury products-including fake Cartier bracelets, necklaces, and rings-on Instagram as well as their own websites. The aleged criminals openly posted photos of counterfeit Cartier jewelry, with a description of the infringing product on Instagram, but on Amazon and other websites, they created product detail pages for generic products with no indication of infringement. The defendants then provided customers on Instagram a link to the generic product on Amazon or other websites, and they told customers if they purchased the generic item, they would receive a counterfeit Cartier product.

09:16 EDT Global Tech Industries contacts FINRA to investigate amid naked short selling - Global Tech Industries Group announced that in light of the apparent consistent naked short selling of the Company's shares, including Monday's high-volume short selling at the market close, the Company has taken, and intends to take, certain actions in an attempt to protect the interests of shareholders. The company said, " First, the Company has contacted FINRA and requested that they fully investigate the matter. The Company intends to cooperate with FINRA in that regard. Second, the Company will be contacting market makers in the Company's shares and requesting that each of them review their quoting and trading activity in GTII to determine whether they have been engaging in "bona fide market making" and their firm's current policies and procedures to ensure they are sufficient to assess whether their firm's quoting and trading activity in GTII comport with its "bona fide market making" obligations. The Company has become concerned with the market making activity in its shares as it appears that certain market makers have failed to post regular or continuous proprietary quotations that are at or near the market on both sides and that are communicated and represented in a way that makes them widely accessible to investors and other broker-dealers. Their failure to meet this requirement, as well as other applicable requirements, would bring into question whether they are engaging in "bona fide market making" and can avail themselves to any "locate" exemptions afforded to bona fide market makers when executing short sales. We also intend to address this issue with FINRA. Finally, the Company will also be reviewing with its legal team other potential actions it can take to protect the Company and its shareholders from such abusive trading practices. Settlement issues resulting from naked short selling, in addition to artificially diluting the Company's shares, can also impede the Company's ability to deliver dividends to shareholders of record and deprive shareholders of voting rights regarding the Company, all of which adversely affect our shareholders and the Company. The Company is pursuing several promising acquisitions that we believe would benefit our shareholders and we intend to do everything reasonably possible to ensure that those engaging in abusive naked short selling practices in our shares do not jeopardize our ability to complete those transactions."

09:07 EDT Wrap announces NDTC endorsement for BolaWrap technology - Wrap Technologies announced an official endorsement from the National De-escalation Training Center for the Company's BolaWrap Remote Restraint technology.

09:05 EDT Arcimoto announces EV financing availability through FreedomRoad - Arcimoto has entered into an agreement with FreedomRoad Financial, a loan production office of Evergreen Bank Group, to provide consumers with vehicle financing for Arcimoto's family of EVs.

09:05 EDT Velodyne files patent infringement complaint with ITC against Ouster - Velodyne Lidar (VLDR) announced that the Company is filing a patent infringement complaint with the U.S. International Trade Commission against Ouster (OUST), requesting that the Commission institute an investigation under section 337 of the Tariff Act of 1930. Velodyne also filed a patent infringement complaint against Ouster in the U.S. District Court for the Northern District of California, seeking an injunction and monetary damages. Velodyne's complaint asks the ITC to investigate unlawful imports of Ouster lidar sensors that are alleged to infringe Velodyne's patents relating to lidar technologies. Velodyne's complaint requests that the ITC issue a limited exclusion order and a cease and desist order against Ouster and Ouster's contract manufacturer, to bar the importation into the United States of Ouster's rotational lidar devices, components, and products that are alleged to infringe Velodyne's patents. Earlier this year, the U.S. Court of Appeals for the Federal Circuit upheld the patentability of all challenged claims in Velodyne's pioneering 7,969,558 patent. The '558 patent relates to a novel lidar-based 3D point cloud measuring system used in multiple industries and applications. Velodyne is focused on advancing its strong smart vision products to meet the large market needs of robotics, industrial, intelligent infrastructure, autonomous vehicles, and advanced driver assistance systems , and Velodyne's patent portfolio protects the substantial investment it is making in these advances. "Velodyne invented rotational lidar and our Company spends significant financial and human resources on research and development to advance smart vision technology," said Dr. Ted Tewksbury, CEO, Velodyne Lidar. "Velodyne has a history of vigorously protecting this investment by taking strong and successful legal action against companies that infringe on our intellectual property and this action is no different."

09:03 EDT Sidus Space announced as teammate on $3.5B NASA xEVAS contract - Sidus Space announced that it is part of the Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity, or xEVAS, services contract. The Exploration Extravehicular Activity Services, or xEVAS Program is expected to include the design, development, production, hardware processing, and sustainment of an integrated Extravehicular Activity, or EVA, capability that includes a new Spacesuit and ancillary hardware, such as Vehicle Interface Equipment and EVA tools. This EVA capability is to be provided as a service for the NASA International Space Station, or ISS, Artemis Program and Commercial Space missions. The xEVAS contract has a potential value of $3.5B through 2034 with a 10-year base contract plus two option years. NASA awarded the contract to Collins Aerospace and Axiom Space. Sidus is a teammate with Collins Aerospace through the life cycle of the program as a major subcontractor during the period of performance of the NASA xEVAS contract and other contracts with independent commercial entities.

09:02 EDT Kintara Therapeutics' VAL-083 granted Fast Track Designation for GBM - Kintara Therapeutics' VAL-083 has been granted Fast Track Designation by the FDA for the treatment of patients with newly-diagnosed unmethylated glioblastoma, or GBM. FTD also allows for 'rolling review', whereby Kintara may submit completed sections of the VAL-083 NDA as they become available, rather than at the end of development.

08:57 EDT Acadia jumps after FDA posts briefing docs for Nuplazid review - The FDA has posted briefing documents ahead of the June 17 meeting of the Psychopharmacologic Drugs Advisory Committee that is being convened to discuss supplemental new drug applications 210793-s008 and 207318-s011, efficacy supplement resubmission for Nuplazid, or pimavanserin, tablets, submitted by Acadia Pharmaceuticals, for the proposed treatment of hallucinations and delusions associated with Alzheimer's disease psychosis. The documents state in part: "At a May 2017 End-Of-Phase 2 meeting, the Agency agreed that the treatment of hallucinations and delusions in "dementia-related psychosis" was a potentially approvable indication. However, the Agency expressed concerns about basing a regulatory decision on a single, randomized withdrawal study (e.g., the Agency pointed out that one of the strongest factors supporting the approval of pimavanserin for treatment of hallucinations and delusions in PDP was the number of complete responders compared with placebo-and this data would not be obtained with a randomized withdrawal study). The Applicant noted that the randomized withdrawal study design could provide data about the durability of pimavanserin's possible effect given the results of Study 019 and that it might ameliorate enrollment difficulties (with all patients initially offered active drug). After the discussion, the Agency agreed that the randomized withdrawal trial would be acceptable as a well-controlled trial for sNDA submission for the indication of hallucinations and delusions associated with dementia-related psychosis. The Agency agreed with the proposed Study 045 phase 3 randomized withdrawal study population as long as subjects were stratified by their current clinical diagnosis (i.e., dementia subtype), and noted that labeling would reflect the actual composition and response of subjects enrolled in the study... At a December 2021 Type B guidance meeting, the Applicant reviewed their plan for a resubmission based on new analyses of Study 045 data and additional information regarding the adequacy of Study 019. The Applicant notified the Division about a change in the proposed indication and described their intent to focus on hallucinations and delusions associated with ADP... The current sNDA resubmission is for the treatment of hallucinations and delusions associated with ADP." In pre-market trading, Acadia shares have jumped $5.35, or 33%, to $21.60. Reference Link

08:47 EDT Sky Technologies announces name change to SKYX Platforms Corp. - SQL Technologies announced that it changed its corporate name to SKYX Platforms Corp. in anticipation of its initial commercialization planned for the second half of 2022. The Company's ticker symbol on the Nasdaq will remain "SKYX", and the CUSIP number for the Company's common stock will remain 78471E105. Outstanding stock certificates for shares of the Company continue to be valid and need not be exchanged. The corporate name change was approved by the Company's stockholders at the Annual Meeting of Stockholders held on June 14, 2022.

08:46 EDT Avinger announces KOL presentations, live case transmission at LINC 2022 - Avinger announced two podium presentations and a live case transmission featuring the company's Lumivascular technology at the Leipzig Interventional Course 2022, which took place June 6 through June 9. Key opinion leaders in the fields of interventional cardiology and endovascular interventions highlighted Avinger's Lumivascular technology in the following sessions: Dr. Arne Schwindt, a vascular surgeon at St. Franziskus Hospital in Munster, Germany and a pioneer in the OCT-guided treatment of vascular disease, featured Avinger's Pantheris SV OCT-guided atherectomy system and his single center experience with the device in his presentation, "OCT-guided Atherectomy for BTK-Disease, Clinical Outcomes in a Prospective and Analyzed Patient Cohort." Dr. Michael Lichtenberg, head of the department of angiology at Klinikum Arnsberg and past president of the German Society for Angiology, presented data from the INSIGHT trial designed to evaluate the safety and effectiveness of Avinger's Pantheris OCT-guided atherectomy system for treating in-stent restenosis in lower extremity arteries. His presentation was entitled, "Treatment of ISR Lesions with the Pantheris Atherectomy Catheter." Dr. Arne Schwindt and Dr. Safa Al-Qudah also performed a live endovascular procedure from St. Franziskus Hospital, featuring Pantheris treatment of a 65-year-old female with restenosis of a previously placed nitinol stent in the superficial femoral artery. The case illustrated the benefits of onboard image-guidance for treating the recurrent blockage without any negative interactions with stent struts and resulted in an excellent outcome for the patient.

08:45 EDT Vicinity Motor completes extension of maturity date on C$10M debenture - Vicinity Motor announces that it has completed the extension of the maturity date of its 8% unsecured debenture in the principal amount of CAD$10,300,000 by a further year to October 4, 2023. In consideration for the extension, the Company has issued to the debt holders, 1,000,000 share purchase warrants exercisable until October 4, 2023 at an exercise price of $2.25 per common share. The New Warrants will bear a four month and one day restricted period from the date of issuance. 412,000 share purchase warrants dated October 4, 2021 that were issued in connection with the original debt issuance, have been cancelled as part of the debt extension.

08:42 EDT PharmaCyte Biotech issues follow up response to Iroquois Capital's 2nd letter - PharmaCyte Biotech issued the following statement in response to the second letter issued by Iroquois Capital on June 9: "We Take Issue with Iroquois' Unfounded Statements On June 7 we issued a detailed letter to our shareholders outlining our growth strategy and additional steps being taken to enhance long-term shareholder value, and we have received positive responses from many shareholders. We have always encouraged feedback from shareholders, which is how our relationship with Iroquois began. However, we find Iroquois' decision to continue to publicly issue unfounded statements that misrepresent our actions troubling and potentially detrimental to long-term shareholder value...We remain focused on what matters most - the development of our cellulose-based live-cell encapsulation technology, which we believe holds tremendous promise for treating various diseases that have often been addressed unsuccessfully, including cancer, diabetes and malignant ascites. As we have stated, we are making substantial progress toward a Phase 2b clinical trial for a promising therapy for pancreatic cancer. We have accelerated preparations for the clinical trial for this therapy so that we will be ready to enroll our first patient and begin the clinical trial almost immediately upon the FDA lifting the clinical hold. We believe this accelerated approach will save approximately six months or more of time from what was originally estimated. We are confident that our previously stated strategy will deliver exponentially higher shareholder value over time and that Iroquois' persistence in raising issues that are already being addressed is an unnecessary distraction that does not benefit shareholders."

08:41 EDT America First announces 12% increase in quarterly, supplemental distribution - America First Multifamily Investors announced that the Board of Managers of Greystone AF Manager declared a cash distribution to the Partnership's Beneficial Unit Certificate, BUC, holders of 57c per BUC. The distribution consists of a regular quarterly distribution of 37c per BUC plus a supplemental distribution of 20c per BUC. The distribution is payable on July 29, 2022 to BUC holders of record as of the close of trading on June 30, 2022. The BUCs will trade ex-distribution as of June 29, 2022. The increase in the regular quarterly distribution to 37c per BUC represents a 12% increase from the previous quarterly distribution of 33c per BUC, which was declared in March 2022. The supplemental distribution of 20c per BUC reflects a portion of the Partnership's recent gains on the sale of its Vantage investments. The supplemental distribution has been declared in connection, and will be paid together, with the regular quarterly distribution.

08:38 EDT Blue Hat regains compliance with Nasdaq minimum bid price requirement - Blue Hat Interactive Entertainment Technology announced that on June 13, 2022 it received a letter from the Listing Qualifications Department of Nasdaq Stock Market LLC notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement and the matter is closed. On June 18, 2021, the Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until December 15, 2021 to regain compliance. On December 16, 2021, the Company received a second 180-day extension from Nasdaq or until June 13, 2022 to regain compliance. Effective May 27, 2022, the Company effected a 1-for-10 reverse stock split. The Letter noted that as of June 10, 2022, Blue Hat evidenced a closing bid price of its ordinary shares at or greater than $1.00 per share minimum requirement for the past 10 consecutive business days. Accordingly, Blue Hat has regained compliance with Nasdaq Marketplace Rule 5550(a)(2), and Nasdaq considers the matter closed.

08:37 EDT Evoke Pharma announces approval of GIMOTI to Florida State Medicaid program - Evoke Pharma announced that the Florida Medicaid Pharmaceutical & Therapeutics Committee has approved adding GIMOTI, the Company's novel treatment solution meant to treat symptoms associated with acute and recurrent diabetic gastroparesis, to the Florida Medicaid Preferred Drug List, PDL, effective immediately. "We view this addition to the Florida Medicaid PDL as a win for patient access to this important medicine for diabetic gastroparesis patients, who have very limited options to obtain symptomatic relief. In a world where many new products are excluded from formularies and patient access is denied, this decision is a significant commercial milestone for GIMOTI," stated Matt D'Onofrio, MBA, Evoke Pharma's Chief Business Officer. "Medicaid approvals across various jurisdictions are one of the primary components of our business plan to increase GIMOTI access. With this addition, we believe we are steadily executing the right strategies to ensure that healthcare providers around the country have the option to make GIMOTI the standard of care for diabetic gastroparesis."

08:35 EDT Genasys announces new government, enterprise GEM software contracts - Genasys announced new, multi-year Genasys Emergency Management, GEM, software-as-a-service, SaaS, contracts in Indiana, New Jersey, New York, Oklahoma, Texas and Washington. The contracts include an enterprise emergency management services agreement with MetLife Stadium in East Rutherford, New Jersey. "Our GEM software has replaced competitors' services in almost all of the new contracts we have announced to date," said Richard Danforth, Chief Executive Officer, Genasys Inc. "GEM is currently used by cities, counties, agencies, and enterprises in 17 U.S. states and four countries to help protect citizens, employees, and event spectators." Danforth added, "The new GEM contracts include 13 counties in Indiana, Oklahoma and Texas. More than 430,000 city and county residents are covered by GEM under these government agreements. Our software business pipeline continues to grow, and we anticipate announcing several more government and enterprise contracts this fiscal year."

08:35 EDT Alcoa announces $51M project to increase Mosjoen smelter production capacity - Alcoa announced a $51M project to increase the production capacity at its Mosjoen smelter in Norway by 14,000 metric tons per year, or mtpy. Alcoa's Mosjoen location currently has a nameplate capacity of 200,000 mtpy, and the investment is expected to increase that capacity to 214,000 mtpy by the end of 2026. Amperage to the site's two potlines will be increased via improved electrical infrastructure, including the installation of new high voltage cabling and switching equipment. The planned investment will also improve the site's existing anode production processes.

08:34 EDT AMN Healthcare announces $250M share repurchase program - The Board of Directors of AMN Healthcare Services, authorized an additional $250 million under the Company's repurchase program for the company's common stock. The Company has repurchased 6.76M shares of common stock at an average price of $77.44 per share excluding broker's fees, resulting in an aggregate purchase price of $523.5M, under the Share Repurchase Program since first authorized in 2016. Since the beginning of the second quarter, the Company has repurchased 1.88M shares at an average price of $92.65 for $173.8M. The total remaining dollar value of common stock that may be repurchased under the Increased Company Repurchase Program is approximately $326.3M.

08:34 EDT Creative Medical Technology, Greenstone Bioscience to develop stem cell platform - Creative Medical Technology has signed an agreement with Greenstone Biosciences for the development of a human induced pluripotent stem cell - iPSC - pipeline for the company's ImmCelz platform. This project will be identified as iPScelz. Beyond the therapeutic benefits offered by iPSC, the iPScelz pipeline for ImmCelz aims to enable the ability for large scale production and sustainability, while helping to reduce long term costs of manufacturing.

08:33 EDT Lixte Biotechnology appoints Rene Bernards to board of directors - LIXTE Biotechnology Holdings announced the appointment of Professor Rene Bernards to its Board of Directors. Professor Bernards will serve as an independent director. Bernards is a leader in the field of molecular carcinogenesis, working at the Netherlands Cancer Institute in Amsterdam.

08:28 EDT Recruiter.com teams with Professional Diversity Network - Recruiter.com Group (RCRT) announces its partnership with Professional Diversity Network IPDN), and educational and employment opportunities for diverse individuals. "PDN is proud to partner with Recruiter.com to help employers access diverse talent," said Adam He, CEO of PDN. "As a top diversity recruitment platform offering recruitment events and job posting solutions, PDN offers a unique and scalable talent acquisition channel for reaching diverse candidates. PDN's collaboration with Recruiter.com will help distribute job postings across Recruiter.com's career communities for added exposure. PDN will also be proud to be the Official Partner of Recruiter.com's new career community for Diversity professionals."

08:27 EDT Recruiter.com partners with Professional Diversity Network - Recruiter.com Group (RCRT) is pleased to announce its partnership with Professional Diversity Network (IPDN). Through the partnership, Recruiter.com and PDN will jointly distribute job postings and co-market their diversity recruitment offerings. Recruiter.com will launch a specialized career community focused on diversity, which PDN will sponsor, and offer a new diversity upgrade for its job posts across its career communities. PDN will distribute these upgraded jobs to its online career sites to showcase these jobs to its professional audience.

08:24 EDT Cuentas regains compliance with Nasdaq listing rules - Cuentas announced that it has regained compliance with Nasdaq listing rules 5605(b)(1) and 5605(c)(2) following the recent appointments of two independent board members to the board of directors - Sandra Orihuela and Sara Sooy. As previously disclosed, Ms. Sooy was appointed to the audit committee and Ms. Orihuela was appointed to the compensation committee.

08:22 EDT Vimeo reports May revenue up 16% - Vimeo reports May monthly metrics, with revenue up 16% and Average Revenue Per User up 11% y/y. Reference Link

08:19 EDT Roblox reports May DAUs 50.4M, up 17% - Roblox released certain key metrics for May. Daily active users were 50.4M, up 17% year over year. Hours engaged were 3.6B, up 10% year over year. Estimated bookings for May were between $196M and $199M, down 9%-11% year over year. Estimated average bookings per daily active user was between $3.89 and $3.95, down 23%-24% year over year. Revenue is estimated to be between $194M and $197M, up 28% - 30% year over year.

08:18 EDT Pineapple Energy completes sale of headquarters building - Pineapple Energy announced that it sold its headquarters building in Minnetonka to Buhl Investors, a Twin Cities real estate investment firm with a focus on providing highly innovative investment solutions across a variety of product types. Buhl will convert the use of the building to multi-tenant, and Pineapple has agreed to lease approximately 8,500 of the 100,000 square foot facility. Pineapple's corporate operations will be headquartered in the building along with Pineapple's legacy IT Solutions & Services operating segment, which will continue to occupy space in the building until they are sold. The sale price was $6.5M cash. Proceeds net of commissions, fees, closing expenses, and any reserves required under the merger agreement between Pineapple Energy and Communications Systems will be distributed to CVR holders by July 30, 2022. Pineapple's Chief Executive Officer Kyle Udseth commented, "Closing on the sale of the legacy CSI headquarters building is one more positive step in completing the post-merger transition to the new Pineapple Energy and fulfills a CSI obligation to the CVR holders. Even though the CVR transaction is not related to go-forward Pineapple, we do benefit from locating our corporate headquarters in a newly-renovated building on attractive lease terms, which we believe will assist us to attract and retain talent."

08:16 EDT Wave CEO Kirk Simpson steps down, Zahir Khoja to succeed - After 12 years of leading Wave Financial Inc., the company's CEO Kirk Simpson is stepping down at the end of June. Simpson co-founded the company in 2009 with James Lochrie and has been serving as CEO since that time. Wave was acquired by H&R Block in 2019. Zahir Khoja will become Wave's CEO effective July 1. Khoja most recently served as General Manager, North America at Afterpay, a leader in "Buy Now, Pay Later" payments where he led the rapid market expansion overseeing sales, client relationships, business growth, and partnerships. At Wave, Khoja will report to H&R Block President and CEO Jeff Jones, as a member of Block's Senior Leadership Team.

08:14 EDT Rogers Communications to launch 3500 MHz 5G spectrum in Canada - Rogers Communications announced it has started to deploy its 5G 3500 MHz spectrum holdings, with the first location going live in Nanaimo, BC this morning. The company will continue its deployment across Canada, including the urban centres of Calgary, Edmonton, Montreal, Ottawa, Toronto and Vancouver and multiple rural areas. More regions will follow as they are released according to the ISED timetable. Unlocking the 3500 MHz band increases network capacity and will boost speed and deliver ultra-low latency, paving the way for Rogers to offer infinite service possibilities for consumers and business customers, from augmented reality and machine learning to smart homes, vehicles and cities. "As the country's biggest investor in 5G spectrum and the first to launch 3500 MHz, we are excited to expand Canada's largest and most reliable networki to more families, businesses and communities through the deployment of our 3500 MHz spectrum," said Tony Staffieri, President and CEO, Rogers Communications. "Today's deployment builds on our foundational 5G investment in low-band 600 MHz spectrum, so we can usher in a new era of mobile and fixed wireless broadband that will create jobs, fuel innovation and keep our economy competitive."

08:12 EDT Qorvo awarded DoD advanced RF Gallium Nitride program - Qorvo has been selected by the U.S. Department of Defense, DoD, to proceed with the Advanced Integration Interconnection and Fabrication Growth for Domestic State of the Art, SOTA, Radio Frequency Gallium Nitride, GaN, program, also known as STARRY NITE, as part of the Office of Undersecretary of Defense Research & Engineering's microelectronics roadmap. The STARRY NITE program seeks to develop and mature domestic, open SOTA RF GaN foundries in alignment with the DoD advanced packaging ecosystem. The Qorvo team will leverage over 30 years of technology development and a long record of successfully establishing high performance, reliable GaN manufacturing technology to achieve these primary goals: To offer secure, domestic high-volume manufacturing of 90 nanometer GaN foundry processes, along with advanced interconnect features that enable high performing, innovative, and compact solutions for next-generation military and commercial wireless communications systems

08:11 EDT Post Holdings announces plan to expand Post Consumer Brands' Sparks, Nevada - Post announced plans for its Post Consumer Brands business to invest up to $110M to expand its cereal production capacity at its Sparks, Nevada facility. The proposed expansion will provide Post Consumer Brands with additional production volume, addressing capacity constraints to better meet consumer demand, as well as reduce transportation costs to serve West Coast customers more efficiently. Project planning and implementation will begin immediately. "Adding capacity in Sparks will help us balance our network geographically and provide us with greater flexibility to best serve our customers," said Nicolas Catoggio, President and CEO, Post Consumer Brands. "This expansion also provides us the opportunity to work in close partnership with the Sparks community, including local economic development authorities, to create new job growth." The expansion is projected to be completed in 2025, with initial new capacity available late in 2024.

08:10 EDT Walgreens, Greater Than AIDS team with health departments for free HIV testing - Walgreens and Greater Than AIDS, a public information initiative of KFF are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day event in the nation.

08:08 EDT Proterra announces appointment of Hauser to board of directors - Proterra announced the appointment of Jan Hauser to the company's board of directors effective June 9, 2022. Hauser is a retired partner of multi-national professional services firm PricewaterhouseCoopers. With Hauser's appointment, five of Proterra's ten directors are women.

08:08 EDT Rezolve acquires ANY Lifestyle Marketing, terms not disclosed - Rezolve announced it has acquired all the shares in ANY Lifestyle Marketing GmbH, the exclusive marketer for all commercial activities of Radio Group in Germany, as its next step in revolutionizing mobile engagement by disrupting the traditional radio market. The acquisition would enable Rezolve to transform radio advertising by making it interactive with consumers' mobile devices. Radio Group reaches 17 cities across Germany with a daily listener base of over 1.5 million and serves over 7000 business partners. Rezolve bridges the gap between offline and online allowing advertisers to transform traditional media by enabling consumers to buy spontaneously using Rezolve enabled apps. ANY specialises in the marketing of radio advertising, ads, posters and audio-visual advertising, and supports and advises radio stations throughout Germany as well as other program providers in marketing to advertisers. The ANY App, powered by Rezolve technology, will allow radio listeners to communicate with retailers and outlets of their preference to get a 360 experience through this lifestyle integrated multiplatform app.

08:05 EDT BioCardia announces US patent on imaging system for targeting cardiac therapies - BioCardia announces that the United States Patent Office has granted Patent Number 11,357,463: titled, "Target Site Selection, Entry and Update With Automatic Remote Image Annotation", with a patent term that will expire in late 2034. The patent describes advances for image guided delivery of treatments for the heart, describing procedures using interventional biotherapeutic delivery technologies to deliver biologics to specific target sites in the heart. The patented imaging system is designed to enable physicians to bring a previously obtained three-dimensional image of a patient's heart from either MRI or CT scan into a procedure, predefine target sites and annotate the heart images to prepare for therapeutic intervention, and then deliver therapy to these target sites in a controlled fashion. The patent claims a system for fluoroscopic imaging of a patient's heart and means for registering and transposing a three-dimensional image of the heart onto two orthogonal, two-dimensional images which can be marked to show anatomical details as well as treatment planning information in the preoperative three-dimensional image.

08:05 EDT Agco appoints Damon Audia to succeed Andy Beck as CFO effective July 1 - Agco (AGCO) announced that its Board of Directors has appointed Damon Audia to succeed Andy Beck as Senior Vice President and Chief Financial Officer effective July 1. Mr. Audia joins AGCO from Kennametal Inc. (KMT), an industrial technology leader specializing in tooling and wear-resistant solutions, where he served as the CFO since August 2018. Andy Beck will retire from AGCO in early 2023. He will serve as Senior Advisor to both the CEO and the new CFO for the remainder of his tenure. "On behalf of the AGCO team, I want to thank Andy for his outstanding contributions over the past 28 years, the last 20 years as our CFO," said Eric Hansotia, AGCO's Chairman, President and Chief Executive Officer. "Andy has served AGCO with great distinction and loyalty through the years, and we are enormously thankful for his contributions to the Company. He has been a model of corporate leadership and integrity in the industry. We thank him for his continued support into 2023 and we wish him well in his retirement from the Company."

08:04 EDT ViaSat selected by Department of Defense for 5G network research - Viasat has received an award from the Department of Defense through the Information Warfare Research Project to conduct research on the use of 5G to support communications for Expeditionary Advanced Base Operations. The research will focus on network enhancements, command and control and delivering advanced processing through the integration of digital twin software defined network capabilities. This is the third award Viasat has received as a part of the DoD's $600M research initiative partnering with industry and academic leaders to explore and advance the use of 5G technology on the battlefield. Viasat will address specific application areas of 5G dynamic radio frequency (RF) spectrum and adaptive network planning and management to enable Low Probability of Intercept/Low Probability of Detection through enhanced deployment of 5G nodes for EABO.

08:03 EDT Chembio announces expansion of direct-to-consumer commercial channel - Chembio Diagnostics announced the launch of its direct-to-consumer commercial channel for the third-party SCoV-2 Ag Detect Self-Test in the U.S. market. In addition, Chembio is expanding distribution of its SURE CHECK HIV Self-Test to consumers in Brazil and the United Kingdom by broadening the test kit's existing Over-the-Counter, OTC, availability in national pharmacy chains. "We are excited to expand patient access to rapid, accurate and easy to use at home diagnostics across the United States, Brazil and the United Kingdom," said Richard Eberly, Chembio's Chief Executive Officer and President. "We are now offering the SCoV-2 Ag Detect Self-Test via our distribution network and directly through Chembio in the US. In addition, we are now offering our SURE CHECK HIV Self-Test through e-commerce platforms in the UK and Brazil. This commercial expansion increases our addressable market and is intended to enable deeper penetration of the market as at home testing volumes continue to grow. This initiative directly aligns with our goal to focus on higher margin business in growing markets under our Global Competitiveness Program."

08:02 EDT Nexstar, altafiber reach multi-year distribution agreement - Nexstar and altafiber announced that they have reached a comprehensive multi-year distribution agreement covering WDTN-TV, the Nexstar television station serving Dayton, Ohio and national cable news network, NewsNation. Financial terms of the agreement were not disclosed. The agreement will extend the national reach of NewsNation to altafiber's Cincinnati and Dayton subscribers. NewsNation is currently available in approximately 75M television households across the United States.

07:57 EDT Science 37 publishes data from oncology clinical research executive survey - Science 37 Holdings published new data from oncology clinical research executives, indicating three-quarters of all planned new oncology study starts over the next 12 months will include elements of decentralization. Globally, there are already more than 3,700 active oncology clinical trials, with research and development spending projected to top $70 billion in 2022 alone-accounting for around one-third of all drug R&D budgets this year. According to projections, by 2026, we could see more than 10,500 oncology clinical trials. To explore current dynamics and future trends in oncology clinical trial design, Science 37 undertook a global survey of clinical research executives in the oncology space. The study was conducted in March and April of 2022. Among the findings: Almost three-quarters of oncology executives are planning to run either an agile or fully decentralized clinical trial in the next 12 months, up from just half in the previous 12 months. The biggest perceived challenges with traditional oncology clinical trials are Patient Recruitment, Study Start-Up, and Timeline/Delays. The top three perceived benefits of using agile/DCT tools in oncology trials are Increased Patient Retention, Greater Patient Diversity, and Faster Patient Recruitment.

07:45 EDT Digital World Acquisition working toward consummating combination w/ Trump Media - Last night, The Digital World Acquisition Corp SPAC announced that it has been "tirelessly working towards consummating its proposed business combination with Trump Media & Technology Group Corp. and to afford Digital World stockholders, both large and small, the opportunity to participate in the process of the Business Combination. Additionally, Digital Word appreciates that the Securities and Exchange Commission is tasked with protecting investors and is working to provide the SEC staff with information, pursuant to previously disclosed subpoena requests, so that the SEC has what it needs to conduct and conclude its investigation. The Digital World team continues to diligently work towards completing the Business Combination, which includes approximately $1.25 billion of net proceeds to TMTG at close, assuming no redemptions by Digital World stockholders, in order for investors to have the opportunity to participate in the Business Combination." Shares of Digital World Acquisition Corp. are up 5.9% in pre-market trading at $28.92.

07:39 EDT Marimaca Copper announces final results from Phase 5 Metallurgical program - Marimaca Copper announces results of the Phase 5 Metallurgical testing program for the Company's flagship Marimaca Oxide Copper Project, located in northern Chile. The Phase 5 Program represents the most comprehensive metallurgical study completed to date for the MOD and is the final phase expected prior to the planned commencement of the Definitive Feasibility Study. Hayden Locke, President and CEO of Marimaca Copper, commented: "The Phase 5 Metallurgical Program completes the acquisition of an incredibly comprehensive metallurgical dataset for Marimaca. This is a critical de-risking milestone and we are very pleased with results. The results from Phase 5 further improve our confidence in the strong metallurgical performance at the MOD. In addition, several opportunities for optimizing acid consumption while maintaining or improving copper recoveries have been identified and will be integrated into our process design going forward. Similar to the trends identified in previous phases, copper recoveries continue to demonstrate upside beyond those projected by acid solubility and Leaching Potential given the longer leaching cycle of the black oxide component of copper oxide mineralization at Marimaca. This provides opportunities with respect to recoveries in industrial-scale operations beyond the positive results demonstrated in this phase of testing. Marimaca continues to distinguish itself as an exceptionally high-quality copper development project. This year's infill and extensional drilling campaigns are progressing well, and we look forward to delivering our planned updated resource estimate in Q3."

07:38 EDT Adaptive Biotechnologies launches T-Detect Lyme - Adaptive Biotechnologies announced the launch of T-Detect Lyme. This is the company's second test to be made available from its growing T-Detect franchise. The T-Detect test detects an immune response by leveraging the body's unique T-cell response to disease-associated antigens. T-Detect Lyme identifies T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease, to help diagnose early Lyme disease. T-Detect Lyme, administered as a simple blood test, is intended to aid in the diagnosis of early Lyme disease in adult patients demonstrating signs and symptoms. In a clinical validation study among patients with early Lyme disease, the T-cell test was more accurate than leading antibody tests. T-Detect Lyme has a specificity of ~99% and showed more than 1.5 times greater sensitivity than standard two-tiered testing in patients who presented with a bullseye rash.

07:36 EDT Biogen to present new data on SPINRAZA - Biogen will present new data from clinical studies aimed at assessing remaining unmet needs for people living with spinal muscular atrophy, SMA, and evaluating the potential impact of SPINRAZA in different patient populations at the SMA Research & Clinical Care Meeting hosted by Cure SMA this week in Anaheim, Calif. Growing enrollment in the RESPOND study indicate there are residual unmet clinical needs in infants and toddlers with SMA following treatment with Zolgensma. The Phase 4 study is evaluating the clinical benefit and safety of SPINRAZA in infants and toddlers with SMA who have unmet needs following treatment with the gene therapy. Since initial findings from nine patients were shared in March 2022, baseline and safety data from 16 patients enrolled in RESPOND are being presented. All enrolled study participants reported suboptimal clinical status across a variety of measures at baseline, with 13 of 16 showing this in multiple areas, including motor and respiratory functions and swallowing/feeding ability. After beginning SPINRAZA treatment, initial safety findings show three participants experienced a serious adverse event during the study period; none of these events were considered related to SPINRAZA treatment. Biogen will also share final data from Part A of the ongoing, three-part DEVOTE study evaluating the safety and tolerability of investigational, higher doses of nusinersen. Results from Part A suggest that a higher dosing regimen of nusinersen leads to higher levels of the drug in the cerebrospinal fluid and is generally well-tolerated. The most common AEs reported were headache and procedural pain. Two serious AEs were reported in one participant during the study period. No AEs were considered related to nusinersen and some were related to treatment administration.

07:33 EDT Marathon Gold reports first 2022 drill results from Berry, Victory Deposits - Marathon Gold reports the latest drill assay results from the Valentine Gold Project in central Newfoundland. The latest drill results represent fire assay data from the first fifteen diamond drill holes completed as part of the 2022 drill campaign at the Berry Deposit and an additional five holes from 2021 and 2022 drilling at the Victory Deposit. Matt Manson, President and CEO, commented: "Today's results are from the first drill holes completed at the Berry Deposit during our 2022 exploration program. Their purpose is to continue the task of in-filling along the 1.5 kilometre length of the deposit delineated to date. These results will not be included in the upcoming mineral resource update for Berry which is based on drilling completed to the end of November 2021. However, once again we are reporting multiple long intercepts of high-grade mineralisation. Of note in today's release is another significant drill hole from the Victory Deposit, VGD-22-086, which returned 17 metres of high-grade mineralisation starting at just 48 metres down-hole. The location of this drill hole adjacent to the Valentine Lake Shear Zone and well away from the location of the historical Victory Mineral Resources validates our exploration thesis for the area, and points to the potential for new discoveries within the underexplored portions of the Valentine Lake property. Drilling at Berry and Victory, as well as grassroots prospecting along the Eastern Arm of the property, are the priorities for our 2022 exploration program."

07:31 EDT Hertz announces new $2B share repurchase program - Hertz Global Holdings announced that its Board of Directors approved a new $2B share repurchase program. The new authorization is in addition to the $2B share repurchase program announced in November 2021. With approximately $0.2B remaining under the previous authorization, pursuant to which the company has repurchased approximately 88M shares as of June 14, the company now has $2.2B available under the programs.

07:24 EDT Sono Motors partners with Rhenus to optimize solar technology - Sono Motors is working with the Rhenus Group on the use of smart solar technology in last-mile logistics. The aim of the cooperation is to collect extensive solar data in real-world operation on the road to further optimize the potential of Sono Motors' solar technology for use on vans. A first Rhenus Group test vehicle was equipped with irradiance sensors for this purpose and will be on the road for the next 12 months in Berlin, Brandenburg and Mecklenburg-Vorpommern. For comprehensive solar data collection, Sono Motors has equipped the Rhenus 15-tonne truck with 4 light irradiance sensors on the sides and roof. These will immediately record the solar radiation intensity in a long-term test under real conditions. A data logger connected to the data center at Sono Motors via an LTE connection transmits the data. At Sono Motors, all measurement data is linked to concrete results and analyzed and transmitted to Rhenus.

07:19 EDT Kintavar announces results from drilling campaign at Anik project - Kintavar Exploration announced the results of the drilling campaign that was carried out on its Anik project under the option agreement entered on May 20, 2020, with IAMGOLD Corporation. The seven drill holes campaign for a total of 2,145 metres was completed in January 2022 and targeted 3 areas of interest. In the Opawica-West and East areas, the fertile stratigraphic sequence of the Nelligan deposit has been identified and now extends for more than 7 kilometres to the east, directly on the Anik property. The five holes drilled in these two areas intersected favourable lithologies and gold mineralization. In both areas, the northern holes, near the "Footwall" of the Renard Zone, had the best gold intersections, while the ''Hanging Wall'' of the Nelligan system has not yet been investigated. The Opawica-West and East areas are 3 km apart along strike with very limited historical work. The Bobby-Kovi area is located northeast of the Nelligan deposit stratigraphic sequence. The drilling targeted soil and geophysical anomalies located 400 metres south of the Bobby and Kovi gold showings discovered by Kintavar geological team in 2015. Hole ANK-21-26 intersected two anomalous gold zones, the first in a massive sulphide level of a graphitic tuff unit, and the second in a stockwork of mineralized veins and veinlets in an altered gabbro. IAMGOLD is progressing with its exploration program on the Anik property and has completed the payment of its second year of agreement. The 2022-23 exploration plan consists of: Extend the geochemical soil survey over the stratigraphic sequence continuation of the Nelligan deposit. Approximately 8 km of sampling lines are initially planned. Extend the geological exploration and mapping program over the eastern extensions of the Nelligan deposit stratigraphic sequence with particular focus on structural folds and gold in till anomalies. Continue geological exploration and mapping over the western extensions of the Bobby-Kovi stratigraphic sequence and till anomalies. Plan a drilling program to investigate the new targets from the 2022 field season and a follow-up on gold intersections from the 2021 drilling program, specifically Opawica-West. The drilling program and interpretation of results is under the control of IAMGOLD's geological staff, including QPs employing strict protocols consistent with NI 43-101 and industry best practices. The sampling of, and assay data from, the drill core is monitored through the implementation of a quality assurance - quality control program. Drill core is logged and samples are selected by the IAMGOLD geologists and sawn in half with a diamond saw at the project site. Half of the core is retained at the site for reference purposes. Sample intervals may vary from 0.5 to 1.5 metres in length depending on the geological observations. Half-core samples are packaged and transported in sealed bags to ALS Minerals Laboratory located in Val-d'Or, Quebec. A formal chain-of-custody procedure was adopted for security of samples until their delivery at the laboratory. Samples are coarse crushed to a -10 mesh and then a 1,000 gram split is pulverized to 95% passing -150 mesh. ALS processes analytical pulps directly at their facilities located in Val-d'Or which is ISO / IEC 17025 certified by the Standards Council of Canada. Samples are analyzed using a standard fire assay with a 50 gram charge with an Atomic Absorption finish. For samples that return assay values over 5.0 grams per tonne, another pulp is taken and fire assayed with a gravimetric finish. Core samples showing visible gold or samples which have returned values greater than 10.0 grams per tonne are re-analyzed by pulp metallic analysis. IAMGOLD inserts blanks and certified reference standards in the sample sequence for quality control.

07:07 EDT Canadian Solar secures $28M in financing for Lavras II project in Brazil - Canadian Solar has secured 136M Brazilian reais, approximately $28M, non-recourse project financing from Banco do Nordeste do Brasil to support construction and operation of its 79 MWp Lavras II solar power project in Brazil. Lavras II is expected to reach commercial operation in Q2 and will be powered by Canadian Solar high efficiency BiHiKu modules.

07:06 EDT springbig completes business combination with Tuatara Capital Acquisition - springbig and Tuatara Capital Acquisition Corporation announced that they have completed their previously announced business combination. The Business Combination was approved at a special general meeting of TCAC shareholders on June 9, 2022. In connection with the closing of the Business Combination, TCAC has changed its name to SpringBig Holdings, Inc. The ticker symbols for TCAC's common stock and warrants have been changed to "SBIG" and "SBIGW," respectively, and will begin trading today on the Nasdaq Global Market. springbig is the largest customer loyalty and marketing platform in the cannabis industry and is the provider of choice and trusted partner to many leading cannabis retailers and brands across North America. The Company serves over 1,300 clients with more than 2,400 retail locations, through its suite of category-leading solutions designed to increase customer retention, build customer loyalty, and boost brand awareness through digital marketing and communications and industry-leading reporting and analytics. The Company and TCAC also announced the issuance of $11 million in aggregate principal amount of senior secured convertible notes to a global institutional investor, pursuant to the terms of the previously announced financing transaction. As of the closing of the Business Combination, the previously announced bonus shares have been delivered to non-redeeming shareholders, with each such shareholder receiving one bonus share for each non-redeeming share and a corresponding forfeiture of 1,000,000 shares by TCAC's sponsor.

07:05 EDT Kymera Therapeutics begins dosing in Phase 1 oncology trials of KT-333, KT-413 - Kymera Therapeutics has recently dosed the first patients in separate Phase 1 clinical trials evaluating the STAT3 degrader KT-333 and the IRAKIMiD degrader KT-413. The KT-333 trial includes patients with relapsed/refractory liquid and solid tumors, including T cell lymphomas and leukemia, and the KT-413 study is enrolling patients with relapsed/refractory B cell lymphomas, including MYD88-mutant diffuse large B cell lymphoma. STAT3 is a transcriptional regulator that has been linked to numerous cancers and other inflammatory and autoimmune diseases. KT-333 is a small molecule protein degrader of the STAT3 protein in development for oncology indications. The Phase 1 trial will evaluate the safety, tolerability, PK/PD and clinical activity of KT-333 in adult patients with relapsed and/or refractory lymphomas and solid tumors. KT-413 is being developed initially for the treatment of relapsed/refractory MYD88-mutant DLBCL, with the potential to expand into other MYD88-mutant indications. The Phase 1 trial will evaluate the safety, tolerability, and PK/PD of KT-413 in patients with relapsed and/or refractory B-cell non-Hodgkin's lymphomas.

07:04 EDT PolyPid hosting KOL webinar on managing cost of surgical site infections - PolyPid announced that it will host a key opinion leader webinar on the cost of managing surgical site infections on Thursday, June 23, 2022, at 10:00 AM Eastern Time. The webinar will feature presentations from KOLs Kyle Cologne, M.D., Los Angeles County General - USC Medical Center, who will provide a general-hospital perspective on the cost of managing SSIs, and Elliot Goodman, M.D., Mount Sinai Health System, who will discuss the impact SSIs have on quality measures and performance from an integrated delivery network perspective. The PolyPid leadership team will provide a corporate update, including a discussion on the timing of the topline results following the recent completion of patient enrollment in the SHIELD I Phase 3 study of D-PLEX100 for the prevention of SSIs in abdominal surgery.

07:02 EDT Chicago Atlantic board increases quarterly dividend 17.5% to 47c per share - Chicago Atlantic Real Estate Finance announced that its board of directors has declared a 17.5% increase in the Company's regular quarterly cash dividend to 47c per share for the second quarter of 2022. The dividend, which equates to an annualized rate of $1.88 per common share, is payable on July 15, 2022 to shareholders of record as of the close of business on June 30, 2022. John Mazarakis, Executive Chairman of Chicago Atlantic Real Estate Finance, noted, "We are pleased to grow the dividend once again and provide additional returns to our shareholders. Our portfolio is performing well, and the demand for debt capital from cannabis operators remains strong."

07:01 EDT Boston Scientific to buy majority stake in M.I.Tech Co. for $230M - Boston Scientific announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake, approximately 64%, of M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular, self-expanding metal stents, which have been distributed by Boston Scientific in Japan since 2015. The agreement consists of a purchase price of KRW 14,500 per share, which represents a total of KRW 291.2B or approximately $230M at current exchange rates, subject to closing adjustments. The company expects to complete the transaction in the second half of 2022, subject to customary closing conditions. The impact to GAAP and adjusted earnings per share is expected to be immaterial in 2022.

06:57 EDT Aecom to complete design of new North Shore wastewater treatment plant - Aecom has been selected by Metro Vancouver to design the North Shore Wastewater Treatment Plant, a new tertiary treatment facility that will replace the existing Lions Gate Wastewater Treatment Plant and serve approximately 250,000 residents in the Districts of West and North Vancouver, the City of North Vancouver, and the Squamish and Tsleil-Waututh Nations. In this role, Aecom will provide design completion and construction management services to assist in the transition of the project to the new construction contractor.

06:33 EDT Immunic announces EMPhASIS trial data published - Immunic announced that data from its phase 2 EMPhASIS trial of lead asset, vidofludimus calcium, in patients with relapsing-remitting multiple sclerosis, has been published in the peer reviewed journal, Annals of Clinical and Translational Neurology. Vidofludimus calcium is a novel and second generation selective dihydroorotate dehydrogenase inhibitor without off-target effects on kinases seen with drugs of the same class, which may lead to a better safety and tolerability profile. The inhibition of DHODH has been shown to suppress magnetic resonance imaging brain lesions and disease activity in multiple sclerosis. The paper assessed the safety and activity on MRI-based endpoints as well as clinical and biomarker assessments of vidofludimus calcium in patients with RRMS.

06:21 EDT Zomedica to acquire Revo Squared, terms undislosed - Zomedica announced it has signed a definitive agreement to acquire substantially all of the assets of Revo Squared. Revo's innovative MicroView digital cytology platform will provide veterinarians with image quality while providing the first in-clinic automated slide preparation system. Slide preparation is a critical part of cytology, and slide preparation errors are the number one reason cited by pathologists for being unable to read a slide. The MicroView platform improves practice workflow efficiency by automating the process to assure a consistent smear and stain in order to produce a readable slide.

06:01 EDT W&T Offshore names Jonathan Curth as General Counsel - W&T Offshore announced the appointment of Jonathan Curth to Executive Vice President, General Counsel and Corporate Secretary, effective June 14. Curth has extensive legal experience working with public exploration and production companies. Prior to joining W&T, Curth most recently served as Executive Vice President, General Counsel, Compliance Officer and Corporate Secretary for Vine Energy.

05:27 EDT WISeKey announce 1-for-2 reverse split of American depository shares - WISeKey announced a 1-for-2 reverse split of American depository shares, or ADS, listed on the Nasdaq. Under the current ratio, 1 ADS represents 5 Class B common shares listed on the Swiss Stock Exchange which means that, post-split 1 ADS will represent 10 Class B common shares. The number of shares owned by ADS holders will be adjusted after the closing bell on Wednesday, June 22. There will be no change to the total number of the company's Class B common shares. The ADS holders of record on the effective date of the reverse split will not be required to take any action in connection with the ADS ratio change. The exchange of every two then-held ADSs for one new ADS will occur automatically with the then-held ADSs being canceled and new ADSs being issued by the depositary bank, in each case as of the effective date for the ADS ratio change. WISeKey's ADSs will continue to trade on the Nasdaq under the symbol. No fractional new ADSs will be issued in connection with the change in the ADS ratio. Instead, the fractional entitlements to new ADSs will be aggregated and sold by the depositary bank and the net cash proceeds from the sale of the fractional ADS entitlements will be distributed to the applicable ADS holders by the depositary bank. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, but the company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than 2 times the ADS price before the change.

05:18 EDT Moolec Science to become public through LightJump Acquisition combination - Moolec Science and LightJump Acquisition (LJAQ), a publicly traded special purpose acquisition company, announced the entry into a definitive agreement for a business combination that would result in Moolec Science, a newly created affiliate of Moolec incorporated in Luxembourg, becoming a publicly listed company. Pursuant to the transactions contemplated by the business combination agreement, Moolec and LightJump will ultimately become wholly-owned subsidiaries of the company. The transaction is expected to be completed in the second half of 2022 and upon closing the company is expected to be listed on Nasdaq under the ticker symbol (MLEC). Moolec is a Molecular Farming pioneer in the new food industry that uses plants to produce real animal proteins. Molecular Farming enables the synthesis of real animal proteins' DNA in any seed crop, carefully selecting each protein for its ability to add value in terms of a targeted functionality trait such as clotting, taste, texture, or nutritional value. The resulting proteins can then be used as ingredients in consumer food products providing tastier, more functional, and affordable animal-free protein alternatives. Molecular Farming is unique in its ability to capitalize on the scale that extensive agriculture entails to achieve affordability. It is also cost efficient because it leverages biology, using plants and their inputs - sun, water, and soil - as small factories for the production of animal proteins. The plants are grown through traditional farming practices that result in economies of scale through high productivity volume production. The company's first two products are Chymosin SPC, a bovine protein expressed in safflower that has curdling applications in the cheese industry, and gamma-linoleic acid, or GLA, a nutritional oil technology sourced from Bioceres Crop Solutions. Both products have been cleared by regulatory authorities and the Company is currently ramping up seed inventories. Upon completion of corner stone milestones in these two products, Moolec has accelerated product development efforts to widen its technology reach, by using the two crops that are most broadly used as protein alternatives - soy and peas - to develop actual meat proteins. In addition, Moolec's Molecular Farming platform has the potential to modify and enhance other plants using animal proteins, which could allow the company to possibly consider other market opportunities. Such possible market opportunities include milk, egg, chicken and fish replacements, or other alternative biomaterials and cosmetics. The Moolec Science LightJump Acquisition Corp. business combination sets the company's proforma equity value at $504M. As a result of the transaction, the combined company is expected to be funded with $138M cash held in LightJump's trust account, assuming no LightJump shareholders exercise their redemption rights at closing and before payment of transaction expenses. In addition, LightJump has entered into a backstop agreement with entities affiliated with Moolec to guarantee a minimum of $10M at closing. Under the terms of the proposed transaction: the current shareholders of Moolec will contribute all of their shares of Moolec to the company in exchange for ordinary shares of the Company and LightJump will merge with a newly formed wholly owned subsidiary of the company and LightJump's ordinary shares and warrants will be exchanged for ordinary shares and warrants of the company. This will result in Moolec and LightJump being wholly owned subsidiaries of the company. Cash proceeds raised in connection with the transaction will primarily be used to accelerate the commercialization of late-stage products, Chymosin and GLA; expansion of R&D & Regulatory Approval efforts for the existing product pipeline; funding for team expansion and general corporate expenses; and organic & inorganic growth opportunities. The boards of directors of LightJump and Moolec have approved the proposed transaction. Completion of the proposed transaction is subject to shareholder approval of LightJump and other customary closing conditions, including a registration statement being declared effective by the U.S. Securities and Exchange Commission. The transaction is expected to be completed in the second half of 2022. On June 8, LightJump Acquisition Corp. filed with the SEC a preliminary proxy statement in connection with a proposal to extend the date by which LightJump must consummate a business combination.